As of April 13, 2021, UT Health San Antonio will suspend its administration of the single-dose Johnson & Johnson COVID-19 vaccine. This is per CDC and FDA recommendations while they investigate recent reports of rare, but potentially dangerous, blood clots that may have been related to the Johnson & Johnson vaccine in certain specific patient populations.
Dr. Monica Verduzco-Gutierrez, Rehabilitation Medicine, is quoted in this Chicago Sun-Times story about patients who test negative but still have “long COVID” symptoms (patients referred to as “long-haulers”). She comments that about 12% of the patients she’s seen never had a positive COVID test, but that’s not as important as are the symptoms she must […]
San Antonio Express-News: ‘I wish I had an easy explanation’: Military suicides in COVID era hit a new highApril 12, 2021
Dr. Alan Peterson, STRONG STAR/ Consortium to Alleviate PTSD (CAP)/Psychiatry and Behavioral Sciences, is quoted in this San Antonio Express-News story about military suicides in the COVID era hitting a new high. Read the story.
Dr. Kevin Bieniek, Pathology, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, explains that if a patient is younger, that doesn’t always mean they will have a less severe Chronic Traumatic Encephalopathy (CTE) case and this disease is linked to repetitive trauma that can come in a number of different shapes and forms. Read and […]
Dr. Fred Campbell, General and Hospital Medicine, answered more listener questions on Texas Standard’s Ask a Doctor program about having bad reactions to the vaccine, why it’s important to keep the vaccination record card and the transmission of the virus. Read and listen to the Q&A.
UT Health San Antonio research team tackles childhood obesity with five-year, $1 million grant from Baptist Health FoundationApril 9, 2021
The potentially groundbreaking research led by principal investigator Lily Q. Dong, PhD, professor of cell systems and anatomy at UT Health San Antonio, is testing whether there is a genetic marker of early insulin resistance in youth that could be controlled, thereby preventing obesity and development of Type 2 diabetes. Currently, most studies and treatment focus on adults, and pediatric anti-obesity drugs have limited effect.